Pharmacodynamics of RP 59500 (quinupristin-dalfopristin) administered by intermittent versus continuous infusion against Staphylococcus aureus-infected fibrin-platelet clots in an in vitro infection model.

We evaluated the bactericidal activity of RP 59500 (quinupristin-dalfopristin) against fibrin-platelet clots (FPC) infected with two clinical isolates of Staphylococcus aureus, one constitutively erythromycin and methicillin resistant (S. aureus AW7) and one erythromycin and methicillin susceptible...

Full beskrivning

Bibliografiska uppgifter

I publikationen:	Antimicrob Agents Chemother
Huvudupphov:	Rybak, M J, Houlihan, H H, Mercier, R C, Kaatz, G W
Materialtyp:	Artigo
Språk:	Inglês
Utgiven:	American Society for Microbiology (ASM) 1997
Ämnen:	Research Article
Länkar:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC163915/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9174199/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.41.6.1359
Taggar:	Lägg till en tagg Inga taggar, Lägg till första taggen!